Journal of Ophthalmology / 2016 / Article / Tab 1

Research Article

How Important Is the Etiology in the Treatment of Epiphora?

Table 1

Causes of epiphora, duration of complaints, and relationship with gender.

Patients (/%)Duration of complaints (/%)Sex (%) value
<1 month1 month–1 year1–5 years>5 years

(1) Ocular surface disease63 (38.7)8 (4.9)42 (25.7)13 (7.9)F (57.1)0.083
(a) Dry eye/blepharitis63 (38.7)8 (4.9%)42 (25.7%)13 (7.9%)F (57.1)0.083

(2) Lacrimal pathway diseases79 (48.4)32 (19.6)42 (25.7)6 (3.6)M (52.5)0.663
(a) Chronic dacryocystitis36 (22.1)15 (9.2%)15 (9.2%)6 (3.6%)F (69.4)0.052
(b) Congenital lacrimal stenosis5 (3.06)5 (3.06%)M (60)0.042
(c) Punctum stenosis42 (25.8)13 (7.9%)29 (17.7%)M (66.6)0.233

(3) Eyelid disorders35 (21.4)8 (4.9)26 (15.9)1 (0.6)M (54.3)0.075
(a) Ectropion27 (16.6)5 (3.06%)21 (12.8%)1 (0.6%)M (59.2)0.151
(b) Entropion5 (3.06)1 (0.6%)4 (2.4%)M (60)0.044
(c) Trichiasis/distichiasis6 (3.6)2 (1.2%)4 (2.4%)F (50)0.083

(4) Others4 (2.4)2 (1.2)2 (1.2)F (50)0.083

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.